New TB drugs for the treatment of children and adolescents with rifampicin-resistant TB in Mumbai, India

Médecins Sans Frontières (MSF) clinic in Mumbai, India. To determine the final treatment outcomes, culture conversion and adverse events (AEs) during treatment among children and adolescents (0-19 years) with rifampicin-resistant tuberculosis (RR-TB) who received ambulatory injectable-free treatment...

Celý popis

Podrobná bibliografia

Vydané v:	The international journal of tuberculosis and lung disease Ročník 24; číslo 12; s. 1265
Hlavní autori:	Das, M, Mamnoon, F, Mansoor, H, Meneguim, A C, Singh, P, Shah, I, Ravi, S, Kalon, S, Hossain, F N, Ferlazzo, G, Isaakidis, P, Furin, J, Acharya, S, Thakur, H P
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	France 01.12.2020
Predmet:	Adolescent Antitubercular Agents - adverse effects Child Female Humans India Male Pharmaceutical Preparations Retrospective Studies Rifampin - adverse effects Tuberculosis, Multidrug-Resistant - drug therapy India
ISSN:	1815-7920, 1815-7920
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!